Virso 400 mg is an antiviral medication that contains the active ingredient Sofosbuvir, which is used primarily in the treatment of chronic Hepatitis C virus (HCV) infection. Sofosbuvir is a nucleotide analog polymerase inhibitor that works by blocking the HCV NS5B RNA-dependent RNA polymerase enzyme, an essential component for viral replication. This inhibition stops the virus from multiplying in the body, helping to clear the infection over time.
Virso 400 mg is typically prescribed as part of a combination therapy with other antiviral drugs such as Daclatasvir, Ledipasvir, or Ribavirin, depending on the HCV genotype and patient condition. It is taken orally once daily, usually for a course of 12 to 24 weeks, as determined by a healthcare provider.
This medication has significantly improved cure rates for hepatitis C, offering sustained virologic response (SVR) in the majority of treated individuals. Side effects are generally mild and may include fatigue, headache, nausea, and insomnia. Serious side effects are rare but should be reported immediately.
Virso 400 mg represents a major advancement in hepatitis C treatment, offering hope for a complete cure. However, it should always be used under medical supervision to ensure safety and effectiveness.
Reviews
There are no reviews yet.